Andrew B Siref, Pathology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-717-2875 Fax: 402-717-2875 |
Dr. Gregory S Smith, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 |
Deba Sarma, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 601 N 30th St, Omaha, NE 68131 Phone: 402-449-4630 |
News Archive
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to-file on this product.
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
According to a new study from the UK, transplanted kidneys from patients whose hearts have stopped perform just as well as those from patients who are brain-dead but still alive. The former have been earlier considered to be weaker since the heart had stopped pumping blood into them before transplant. The study was published online by the The Lancet.
In industrialized countries, a particularly high number of people suffer from arteriosclerosis - with fatal consequences: Deposits in the arteries lead to strokes and heart attacks. A team of researchers under the leadership of the University of Bonn has now developed a method for guiding replacement cells to diseased vascular segments using nanoparticles.
"It's not much of a surprise that Monday night's presidential debate, which focused on foreign policy, was consumed by a discussion of defense spending, and security and trade policies," but "it's still disappointing that both President Barack Obama and Republican presidential nominee Gov. Mitt Romney were relatively silent on issues like global health, research, and international aid," Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin writes in the GHTC's "Breakthroughs" blog.
› Verified 4 days ago